MGC Pharmaceuticals Ltd's (ASX:MXC) (LON:MXC) (OTCMKTS:MGCLF) (FRA:H5O) Roby Zomer talks to Proactive's Katie Pilbeam about the completed delivery of their first bulk order in March of ArtemiCTM Rescue to Swiss PharmaCan AG.
He says the 'next step is to convert efforts in research into commercial revenue and take our company towards profitability.... now we're ready'.
The deal equates to around $425,000 (€275,000) in wholesale production revenue to the company. Zomer sales it's time to move all of this development into sales and build a sales team globally.